We applied the detect changes associated with pulmonary exacerbation and Quality of Well-Being scale (QWB) in 28 patients with CF its treatment. (Chest 1990; 98:1081-84) before and after a two-week course of oral ciprofloxacin used to treat pulmonary exacerbations. Tl_ere were signifi-[ QWB ffi Quality of Well-Being scale I cant correlations between changes in QWB and various
patient's overall quality of well-being have not been We believed that it was important to see ffthe QWB available, yet would be of importance.
These measures scale could also capture ch/mges over time, as seen, have the advantage of assessing both benefits and side for example, with clinical deterioration, or, as with the effects of treatment and can express outcome in terms current study, treatment of a pulmonary exacerbation.
•of net benefit since they are not limited to one organ Step No.
Step Definition Weight Performed no major role activity, health related, but did perform self-care activities -.061 1
Mobility Scale
.Performed no major role activity, health related, and did not perform or had more help than usual in -.106 performance of one or more self-care activities, health related mogiobin saturation (SaOz) was measured (with a Nellcor pulse purpose of the system is to express benefits and side effects of a oximeter). These measurements were made on entry into the program in terms of equivalents of'completely well-years of life. treatment course and were repeated two weeks later at the end of The years of life figure is adjusted for diminished quality of life. the treatment course, produced by disease or disability. Scores on the QWB scale are obtained by elassffyi'ng people into one step in each of the scales. Quality of WeU-Being Scale described in Table 1 . In addition, patients indicate the symptom or "The QWB scale is part of a General Health Policy Model? The problem that bothered them most on atmr. titular day ( Table 2 ). The 
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